Home › Lilly And ImaginAb Announce Preclinical Immuno-Oncology Collaboration
 

Keywords :   


Lilly And ImaginAb Announce Preclinical Immuno-Oncology Collaboration

2015-10-14 06:26:33| drugdiscoveryonline News Articles

Eli Lilly and Company (NYSE: LLY) and ImaginAb Inc. are pleased to announce a preclinical research collaboration to study potential novel T-cell-based immuno-oncology therapies.

Tags: collaboration announce lilly preclinical

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.11 Beautiful World CD
24.11VIII
24.11PLUS MADHOUSE( ) 2
24.11KATO 10-1537 415
24.11125f-slim
24.11
24.11olend ona soft bag
24.1110ONKYO
More »